“The accuracy and sensitivity of the X500B LC-MS instrument, with improved robustness, allows for monitoring of manufacturing batches with increased analytical throughput.”
Type of Organization
Sanofi S.A. is a global healthcare leader in biopharmaceuticals. The structural analysis department specializes in mass spectrometry and structural analysis for biologics characterization.
To gain better knowledge of biopharmaceutical products in development by reliable mass spectrometry characterization at the intact protein and peptide level.
- Data Independent Acquisition (DIA)
- Peptide Mapping
- Intact Protein Analysis
- Post-Translational Modification Analysis
- X500B QTOF System
- SCIEX OS Acquisition Software
- BioPharmaView™ Software